Orchid Pharma Limited (NSE:ORCHPHARMA)
India · Delayed Price · Currency is INR 720.00
+16.55 (2.35%)
May 11, 2026, 3:29 PM IST
Orchid Pharma Market Cap
Orchid Pharma has a market cap or net worth of 35.68 billion as of May 11, 2026. Its market cap has decreased by -12.04% in one year.
Market Cap
35.68B
Enterprise Value
37.01B
Revenue
8.11B
Ranking
n/a
PE Ratio
186.59
Stock Price
720.00
Market Cap Chart
Since November 3, 2020, Orchid Pharma's market cap has increased from 727.35M to 35.68B, an increase of 4,805.26%. That is a compound annual growth rate of 102.42%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 11, 2026 | 36.52B | -5.13% |
| Dec 31, 2025 | 38.49B | -58.00% |
| Dec 31, 2024 | 91.65B | 153.62% |
| Dec 29, 2023 | 36.14B | 143.20% |
| Dec 30, 2022 | 14.86B | -7.81% |
| Dec 31, 2021 | 16.12B | 223.64% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Nov 3, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Akums Drugs and Pharmaceuticals | 85.29B |
| Sudeep Pharma | 73.39B |
| Aarti Pharmalabs | 69.46B |
| Sun Pharma Advanced Research Company | 56.17B |
| Innova Captab | 50.11B |
| RPG Life Sciences | 40.74B |
| Solara Active Pharma Sciences | 25.31B |
| Indoco Remedies | 21.04B |